HAMP and myelodysplastic syndrome with ring sideroblasts: The results suggest that expanded but ineffective erythropoietic activity in these patients leads to inappropriately low hepcidin levels in MDS-RARS patients with an SF3B1 mutation, leading ultimately to excess release of iron from the RES and parenchymal iron loading (Ambaglio et al., 2013).